Partnering for FDA Review: Approaches for Preclinical Outsourcing and CRO Evaluation, June 24, 2019

CBSET’s Michael Naimark will be addressing the clinicians and researchers at St. Jude Children’s Research Hospital on the topic: “Partnering for FDA Review: Approaches for Preclinical Outsourcing and CRO Evaluation.”

If you would like more information about this topic or about CBSET, please contact Michael.


Related CBSET brochures:

Related Publications:

wpt-cell-therapy-coverWorld Pharma Today, Cell-based Therapy and FDA Review: Partnering for Success at Your pre-IND Meeting

by Michael Naimark, MS, Director of Business Development at CBSET, Inc.

wpt-stem-cell-auditory-coverWorld Pharma Today: Stem Cell and Regenerative Therapies for Hearing Loss

by Michael Naimark, MS, Director of Business Development at CBSET, Inc. and Marie-Pierre Pasdelou, PharmD, Founder and Chief Development Officer at CILcare